Sofuoglu M - Search Results

1

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

Jensen KP, DeVito EE, Herman AI, Valentine GW, Gelernter J, Sofuoglu M. Jensen KP, et al. Among authors: sofuoglu m. Neuropsychopharmacology. 2015 Nov;40(12):2813-21. doi: 10.1038/npp.2015.131. Epub 2015 May 7. Neuropsychopharmacology. 2015. PMID: 25948103 Free PMC article.

2

Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.

Sofuoglu M, Mouratidis M, Yoo S, Culligan K, Kosten T. Sofuoglu M, et al. Psychopharmacology (Berl). 2005 Sep;181(3):504-10. doi: 10.1007/s00213-005-0010-y. Epub 2005 Oct 12. Psychopharmacology (Berl). 2005. PMID: 15983800 Clinical Trial.

3

Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.

Sofuoglu M, Poling J, Mouratidis M, Kosten T. Sofuoglu M, et al. Psychopharmacology (Berl). 2006 Mar;184(3-4):645-51. doi: 10.1007/s00213-005-0296-9. Epub 2006 Jan 24. Psychopharmacology (Berl). 2006. PMID: 16432681 Clinical Trial.

4

Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokers.

Sofuoglu M, Mouratidis M, Yoo S, Kosten T. Sofuoglu M, et al. Behav Pharmacol. 2006 Dec;17(8):731-5. doi: 10.1097/FBP.0b013e32801155d4. Behav Pharmacol. 2006. PMID: 17110799 Clinical Trial.

5

Self-administration of intravenous nicotine in male and female cigarette smokers.

Sofuoglu M, Yoo S, Hill KP, Mooney M. Sofuoglu M, et al. Neuropsychopharmacology. 2008 Mar;33(4):715-20. doi: 10.1038/sj.npp.1301460. Epub 2007 May 30. Neuropsychopharmacology. 2008. PMID: 17534380 Clinical Trial.

6

Modafinil and nicotine interactions in abstinent smokers.

Sofuoglu M, Waters AJ, Mooney M. Sofuoglu M, et al. Hum Psychopharmacol. 2008 Jan;23(1):21-30. doi: 10.1002/hup.878. Hum Psychopharmacol. 2008. PMID: 17868195 Clinical Trial.

7

Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.

Sofuoglu M, Waters AJ, Mooney M, O'Malley SS. Sofuoglu M, et al. Pharmacol Biochem Behav. 2009 Mar;92(1):135-40. doi: 10.1016/j.pbb.2008.11.004. Epub 2008 Nov 13. Pharmacol Biochem Behav. 2009. PMID: 19041336 Free PMC article. Clinical Trial.

8

Subjective responses to intravenous nicotine: greater sensitivity in women than in men.

Sofuoglu M, Mooney M. Sofuoglu M, et al. Exp Clin Psychopharmacol. 2009 Apr;17(2):63-9. doi: 10.1037/a0015297. Exp Clin Psychopharmacol. 2009. PMID: 19331482 Free PMC article.

9

Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.

Sofuoglu M, Herman AI, Mooney M, Waters AJ. Sofuoglu M, et al. Psychopharmacology (Berl). 2009 Nov;207(1):153-62. doi: 10.1007/s00213-009-1643-z. Epub 2009 Aug 20. Psychopharmacology (Berl). 2009. PMID: 19693492 Free PMC article. Clinical Trial.

10

Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers.

Sofuoglu M, Mitchell E, Mooney M. Sofuoglu M, et al. Hum Psychopharmacol. 2009 Oct;24(7):559-64. doi: 10.1002/hup.1055. Hum Psychopharmacol. 2009. PMID: 19743227 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters